Arbutus Biopharma Corporation (ABUS) dipped -6.97% or -0.28 to $3.74. It is near to 245346 shares traded, which is 140.42% compare to the average total volume 174724. The market cap of ABUS is $207.48 million. The year to date change is -6.47%. The 52 week price range is from $3.2 to $12.6. Price of ABUS have changed -12.04% during last week. It have changed 7.49% over last month, -8.64% over last 3 months, -62.78% over last 6 months and -24.86% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ABUS is 3.86. It is 3.21% above current price. The 200-day Moving Averages for ABUS is 6.47. It is 72.99% above current price. The 52-week High is 12.6. It is 236.90% from the current price. The 52-week Low is 3.2. It is -14.44% from current price.
There are some statistics of ABUS. It is has market cap $207.48 million. The share outstanding is 55.48 million. The average volume is 174724. The percent of top 15 Institution holding is 50.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ABUS is -64.12%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ABUS is -34.25%.